$250,000 grant for 3 years at University of Washington. Dr. McLaughlin used brain imaging and smartphone-enabled technologies to investigate the biology of how stress can lead to anxiety and depression in youth.
$250,000 grant for 3 years at University of Michigan. Anxiety disorders start early in life, affecting one in five children, and often set the stage for later depression, substance abuse, and even suicide. Dr. Kate D. Fitzgerald’s AIM Sullivan Family Rising Star Award is funding research to prevent childhood anxiety
$64,000 grant. Working alongside AIM Scientific Advisory Board member, Dr. Hilary Blumberg, Anjali will investigate potential predictors of suicide in youth and strategies to reduce them, with a focus on brain and symptom changes before and after psychotherapeutic and pharmacological interventions.
Dr. Spencer Evans evaluated the effectiveness of existing assessment tools and treatment strategies for severe irritability as well as exploring novel approaches to personalized assessment and treatment. $70,000
Dr. Marc Weintraub examined the emotional and cognitive pathways linked to severe mental illness in adolescents. His findings include a new approach to treating early symptoms of severe mental illness in teens, holding promise for prevention.
$45,600 AIM grant. Dr. Adam Gazzaley, an AIM Scientific Advisory Board member and founder of UCSF’s Neuroscape, will conduct a pilot study of a novel, adaptive attention training software, Engage, in adolescents who have difficulties with attention.
$50,417 Clinical Science Fellowship award to support research on eating in the absence of hunger and obesity risk among African-American and Latinx youth. The work is being done by Dr. Joya Hampton-Anderson, a clinical post-doctoral researcher in the Department of Psychology at Emory University. A key element in this research
Seed funding for a study of innovative treatment that combines computerized brain training exercises resembling popular video games and intensive “talk therapy.” The research is being done by Dr. Barbara Cornblatt, a Professor of Psychiatry and Molecular Medicine and the Director of the Recognition and Prevention (RAP) Program at Hofstra
